Cirrhosis is a late stage of liver scarring where healthy tissue is progressively replaced by stiff, nonfunctional scar tissue. It develops over years or decades as the liver repeatedly tries to repair itself from ongoing damage, and it affects a staggering number of people: global prevalence reached an estimated 1.7 billion cases in 2021, with over 1.4 million deaths that year alone.
How Scar Tissue Replaces Healthy Liver
Your liver has a remarkable ability to heal. When it’s injured, whether by alcohol, a virus, or fat buildup, specialized cells called stellate cells spring into action. Under normal conditions, these cells sit quietly and store vitamin A. But when the liver is damaged, they transform into a completely different type of cell, one that produces collagen and other tough, fibrous proteins. This transformation involves changes in the activity of several hundred different genes.
In a one-time injury, this repair process works well. The problem starts when the damage never stops. Chronic liver disease keeps sending alarm signals, and the stellate cells keep laying down more and more fibrous tissue. Over time, this excess scar tissue distorts the liver’s internal structure, blocking blood flow and preventing healthy liver cells from doing their job. The progression from mild scarring (fibrosis) to full cirrhosis can take anywhere from a few years to several decades, depending on the cause and how aggressively it’s treated.
What Causes Cirrhosis
Three causes account for the vast majority of cases. Long-term heavy alcohol use damages liver cells directly, and the risk rises sharply with both the amount consumed and the number of years of drinking. Chronic viral hepatitis, particularly hepatitis B and hepatitis C, triggers ongoing inflammation that slowly drives scarring. And metabolic dysfunction-associated steatohepatitis (sometimes called fatty liver disease) has become increasingly common alongside rising rates of obesity and type 2 diabetes.
Less common causes include autoimmune hepatitis, where the immune system attacks the liver; inherited conditions like hemochromatosis (iron overload) and Wilson’s disease (copper buildup); chronic bile duct obstruction; and prolonged exposure to certain medications or toxins. In some cases, no clear cause is identified.
Compensated vs. Decompensated Cirrhosis
One of the most important distinctions in cirrhosis is whether the liver can still keep up with its workload. In compensated cirrhosis, the remaining healthy tissue picks up the slack. You may have no symptoms at all, or only mild ones like fatigue. People in this stage can live 10 to 12 years on average, and many live considerably longer if the underlying cause is controlled.
Decompensated cirrhosis is a different situation entirely. This means the liver can no longer manage its essential functions, and serious complications appear. Median survival drops to just 1 to 2 years without intervention. Clinicians recognize four distinct stages based on what complications are present:
- Stage 1: No enlarged veins in the esophagus or stomach. One-year mortality is about 1%.
- Stage 2: Enlarged esophageal veins have formed but haven’t bled. One-year mortality rises to about 3%.
- Stage 3: Fluid buildup in the abdomen (ascites) is present. One-year mortality jumps to 20%.
- Stage 4: Bleeding from those enlarged veins has occurred. One-year mortality reaches approximately 57%.
The transition from compensated to decompensated cirrhosis is the single most important turning point in the disease. Preventing that shift is the central goal of treatment.
Major Complications
Most complications of cirrhosis stem from one problem: blood can no longer flow easily through the scarred liver. This creates a traffic jam called portal hypertension, where pressure builds in the vein that carries blood from the digestive organs to the liver. That pressure forces blood to find alternate routes back to the heart, and the consequences can be severe.
Enlarged Veins and Bleeding
About 50% of people with cirrhosis develop enlarged, fragile veins (varices) in the esophagus or stomach. Each year, 5 to 15% of those with cirrhosis develop new varices or see existing ones worsen. These veins were never designed to handle high-pressure blood flow, and they can rupture. When bleeding occurs, it stops on its own only about 40% of the time, and the six-week mortality after a bleeding episode exceeds 20%.
Fluid Buildup
Ascites, the accumulation of fluid in the abdomen, is the most common complication of decompensated cirrhosis. It happens because portal hypertension changes how the body handles sodium and water, causing fluid to leak from blood vessels into the abdominal cavity. Mild ascites may cause only bloating and weight gain. Severe cases can make it difficult to breathe and eat, and the fluid can become infected.
Brain Fog and Confusion
The liver normally filters ammonia and other toxins from the blood. When it can’t, those substances accumulate and affect brain function, a condition called hepatic encephalopathy. Early signs are subtle: changes in sleep patterns, mild forgetfulness, trouble concentrating, personality shifts, or deteriorating handwriting. As it progresses, symptoms can escalate to noticeable confusion, slurred speech, sluggish movement, agitation, and in severe cases, loss of consciousness.
How Cirrhosis Is Diagnosed
Cirrhosis is often discovered incidentally during imaging or blood work done for another reason, especially in the compensated stage when symptoms are absent. Several tools help confirm the diagnosis.
A liver biopsy, where a small tissue sample is examined under a microscope, has long been considered the gold standard. But it’s invasive and carries a small risk of complications. Increasingly, a non-invasive test called transient elastography (often known by the brand name FibroScan) is used instead. This device measures liver stiffness by sending a painless vibration through the skin. A stiffness reading above 17.6 kilopascals strongly suggests cirrhosis, with 97% specificity and 77% sensitivity. In practical terms, that means a high reading is very reliable, though some cases of cirrhosis can be missed.
Blood tests also provide important clues. Doctors use a scoring system called MELD-Na, which combines several blood values (bilirubin, creatinine, clotting time, sodium, and albumin) into a single number that estimates how urgently someone needs a liver transplant. Higher scores indicate more severe liver dysfunction and greater urgency for transplantation.
Can Cirrhosis Be Reversed?
For a long time, cirrhosis was considered permanent. That view has changed. Research now shows that liver scarring is a dynamic, two-way process, and removing the cause of damage can allow significant improvement even at advanced stages.
The strongest evidence comes from antiviral treatments. In a five-year study of patients with chronic hepatitis B treated with the antiviral tenofovir, 74% improved enough on biopsy that they were no longer classified as cirrhotic. Among hepatitis C patients who achieved a lasting viral cure, 82% of those with significant scarring saw their fibrosis scores decrease. Even among patients specifically starting at the cirrhosis stage, 35% achieved at least a two-grade improvement in scarring.
That said, reversal is more likely in earlier cirrhosis where the scar tissue hasn’t become heavily cross-linked and the liver’s blood vessel architecture is less distorted. Advanced, long-standing cirrhosis with extensive structural changes is far harder to undo. The takeaway is clear: the earlier the underlying cause is treated, the better the chance the liver can recover meaningful function.
Living With Cirrhosis
Managing cirrhosis centers on two priorities: treating whatever caused the liver damage and preventing complications. For alcohol-related cirrhosis, that means stopping drinking entirely. For viral hepatitis, it means antiviral therapy. For fatty liver disease, it means weight loss, blood sugar control, and dietary changes.
Nutrition plays a significant role. Muscle wasting is common in cirrhosis, and inadequate protein accelerates it. Current guidelines recommend 1.0 to 1.5 grams of protein per kilogram of body weight per day. Studies show that dropping below 0.5 grams per kilogram leads to measurably increased muscle breakdown. During an acute episode of hepatic encephalopathy, protein may be temporarily reduced to 0.6 to 0.8 grams per kilogram, but it should be increased again quickly once the episode resolves.
Sodium restriction matters if you have ascites. Keeping intake at or below 2,000 milligrams per day (roughly one teaspoon of table salt) helps control fluid retention. People who also have high blood pressure may benefit from staying closer to 1,500 milligrams. Regular screening for enlarged esophageal veins and liver cancer is standard, since catching these complications early dramatically improves outcomes. For people with decompensated cirrhosis who don’t respond to medical management, liver transplantation remains the most definitive treatment.